359625-79-9 Usage
General Description
MIN-101 is a novel compound with potential antipsychotic properties designed to target serotonin and sigma receptors in the brain. It is being developed as a treatment for schizophrenia and other psychotic disorders. MIN-101 has shown promise in clinical trials for its ability to reduce negative symptoms and improve overall cognitive function in patients with schizophrenia. It is believed to work by modulating the dopamine and glutamate neurotransmitter systems, which are implicated in the pathophysiology of schizophrenia. MIN-101 has the potential to offer a new treatment option for patients with schizophrenia and other psychotic disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 359625-79-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,5,9,6,2 and 5 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 359625-79:
(8*3)+(7*5)+(6*9)+(5*6)+(4*2)+(3*5)+(2*7)+(1*9)=189
189 % 10 = 9
So 359625-79-9 is a valid CAS Registry Number.
359625-79-9Relevant articles and documents
Novel cyclic amide derivatives
-
, (2008/06/13)
Novel compounds represented by the following formula (I) that act as a ligand to sigma receptor/binding cite and a medicament comprising the same as an active ingredient: wherein X represents an alkyl group, an aryl group, a heterocyclic group or the like; Q represents a group represented by —CH2—, —CO—, —O—, —CH(OR7)— or the like wherein R7 represents a hydrogen atom, an alkyl group or the like; n represents an integer of from 0 to 5; R1 and R2 each represent a hydrogen atom, an alkyl group or the like; B represents either of the following groups: wherein R3, R4, R5, and R6 each represent a hydrogen atom, a halogen atom, an alkoxyl group or the like; m represents 1 or 2; and the ring of: represents an aromatic heterocyclic ring.
